Preclinical Evaluation of Novel 64Cu-Labeled Gastrin-Releasing Peptide Receptor Bioconjugates for PET Imaging of Prostate Cancer-Reference-Cited by-同舟云学术

Preclinical Evaluation of Novel 64Cu-Labeled Gastrin-Releasing Peptide Receptor Bioconjugates for PET Imaging of Prostate Cancer

Published:2021-01-12 Issue:7 Volume:32 Page:1290-1297
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Makris George¹,Shegani Antonio¹²,Kankanamalage Pavithra H. A.¹,Kuchuk Marina¹,Bandari Rajendra P.³,Smith Charles J.¹³⁴^ORCID,Hennkens Heather M.¹⁵^ORCID

Affiliation:

1. Research Reactor Center, University of Missouri, Columbia, Missouri 65211, United States

2. Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research “Demokritos”, 15310 Athens, Greece

3. Research Service, Harry S. Truman Memorial Veterans’ Hospital, Columbia, Missouri 65201, United States

4. Department of Radiology, University of Missouri School of Medicine, Columbia, Missouri 65212, United States

5. Department of Chemistry, University of Missouri, Columbia, Missouri 65211, United States

Funder

U.S. Department of Veterans Affairs

Fulbright Foundation in Greece

University of Missouri

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.0c00656

Reference27 articles.

1. Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy

2. Peptide Receptor Radionuclide Therapy: An Overview

3. Peptides and Peptide Hormones for Molecular Imaging and Disease Diagnosis

4. Prostate Cancer Theranostics Targeting Gastrin-Releasing Peptide Receptors

5. Bombesin Receptor Antagonists May Be Preferable to Agonists for Tumor Targeting

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Evaluation of a Novel c-Met-Targeting Cyclic Peptide as a Potential Diagnostic Agent for Colorectal Cancer;Molecular Pharmaceutics;2024-06-10

2. PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA;International Journal of Molecular Sciences;2022-09-02

3. p-NCS-Bn-NODAGA as a bifunctional chelator for radiolabeling with the 186Re/99mTc-tricarbonyl core: Radiochemistry with model complexes and a GRPR-targeting peptide;Nuclear Medicine and Biology;2022-05

4. Development and biodistribution studies of 77As-labeled trithiol RM2 bioconjugates for prostate cancer: Comparison of [77As]As-trithiol-Ser-Ser-RM2 vs. [77As]As-trithiol-Glu-Ser-RM2;Nuclear Medicine and Biology;2022-05

5. Bioconjugated chelates based on (methylpyridinyl)tacn: synthesis, 64Cu labeling and in vitro evaluation for prostate cancer targeting;Metallomics;2022